Overview
Isolated sulfite oxidase deficiency (ISOD) is an extremely rare autosomal recessive metabolic disorder caused by mutations in the SUOX gene, which encodes the enzyme sulfite oxidase. This enzyme is essential for the final step in the degradation of sulfur-containing amino acids (methionine and cysteine), converting toxic sulfite to sulfate. When this enzyme is deficient, sulfite and other toxic metabolites (S-sulfocysteine, thiosulfate, taurine) accumulate in the body, causing severe damage primarily to the central nervous system. The disease predominantly presents in the neonatal period with intractable seizures, feeding difficulties, and progressive encephalopathy. Affected infants typically develop severe intellectual disability, spasticity, microcephaly, and characteristic lens dislocation (ectopia lentis). Brain imaging often reveals extensive white matter changes, cystic encephalomalacia, and cerebral atrophy. The clinical presentation closely resembles molybdenum cofactor deficiency, which also impairs sulfite oxidase activity but additionally affects xanthine dehydrogenase and aldehyde oxidase. The two conditions can be distinguished biochemically, as isolated sulfite oxidase deficiency shows elevated sulfite and S-sulfocysteine but normal uric acid and xanthine levels. A milder, late-onset form has been described in rare cases, presenting with developmental delay and movement abnormalities rather than the devastating neonatal course. Unfortunately, there is currently no effective cure or disease-modifying treatment for isolated sulfite oxidase deficiency. Management is primarily supportive, focusing on seizure control (which is often refractory to standard anticonvulsants), nutritional support, and physical therapy. Dietary restriction of methionine and cysteine has been attempted with limited success. The prognosis for the severe neonatal form is generally poor, with significant morbidity and early mortality.
Also known as:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Isolated sulfite oxidase deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Isolated sulfite oxidase deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Isolated sulfite oxidase deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Isolated sulfite oxidase deficiency.
Community
No community posts yet. Be the first to share your experience with Isolated sulfite oxidase deficiency.
Start the conversation →Latest news about Isolated sulfite oxidase deficiency
No recent news articles for Isolated sulfite oxidase deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Isolated sulfite oxidase deficiency
What is Isolated sulfite oxidase deficiency?
Isolated sulfite oxidase deficiency (ISOD) is an extremely rare autosomal recessive metabolic disorder caused by mutations in the SUOX gene, which encodes the enzyme sulfite oxidase. This enzyme is essential for the final step in the degradation of sulfur-containing amino acids (methionine and cysteine), converting toxic sulfite to sulfate. When this enzyme is deficient, sulfite and other toxic metabolites (S-sulfocysteine, thiosulfate, taurine) accumulate in the body, causing severe damage primarily to the central nervous system. The disease predominantly presents in the neonatal period with
How is Isolated sulfite oxidase deficiency inherited?
Isolated sulfite oxidase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Isolated sulfite oxidase deficiency typically begin?
Typical onset of Isolated sulfite oxidase deficiency is neonatal. Age of onset can vary across affected individuals.